Evaluation of Safety and Efficacy of Botulinum Toxin Type A (BOTOX®) to Treat Urinary Incontinence Due to Neurogenic Detrusor Overactivity or Overactive Bladder in Korea

CompletedOBSERVATIONAL

Enrollment

523

Participants

Timeline

Start Date

February 28, 2014

Primary Completion Date

July 31, 2016

Study Completion Date

July 31, 2016

Conditions

Urinary IncontinenceUrinary Bladder, Overactive

Interventions

BIOLOGICAL

botulinum toxin Type A

Botulinum toxin Type A treatment for Neurogenic Detrusor Overactivity or Overactive Bladder as per local standard of care in clinical practice.

Trial Locations (1)

Asan Medical Center, Seoul